BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8412328)

  • 21. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
    Tang X; Wu D; Xue Y; Zhu M; Lu D; Ruan C
    Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors.
    Paquette RL; Nicoll J; Chalukya M; Elashoff D; Shah NP; Sawyers C; Spiteri E; Nanjangud G; Rao PN
    Cancer Genet; 2011 Jul; 204(7):392-7. PubMed ID: 21872826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype.
    Smith MR; Mohamed AN; Karanes C
    Leukemia; 1993 Feb; 7(2):177-80. PubMed ID: 7678877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin and T cell receptor gene rearrangements in Philadelphia chromosome-positive leukemia: a different involvement pattern in blast crisis and acute leukemia.
    Ohyashiki JH; Ohyashiki K; Tauchi T; Saito M; Nakazawa S; Kimura N; Toyama K
    Leukemia; 1990 Aug; 4(8):572-9. PubMed ID: 2143795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
    Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
    Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
    Martinelli G; Ottaviani E; Buonamici S; Isidori A; Borsaru G; Visani G; Piccaluga PP; Malagola M; Testoni N; Rondoni M; Nucifora G; Tura S; Baccarani M
    Haematologica; 2003 Nov; 88(11):1221-8. PubMed ID: 14607750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations.
    Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R
    Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic myelogenous leukemia molecular signature.
    Nowicki MO; Pawlowski P; Fischer T; Hess G; Pawlowski T; Skorski T
    Oncogene; 2003 Jun; 22(25):3952-63. PubMed ID: 12813469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein.
    Watanabe T; Kataoka T; Mizuta S; Kobayashi M; Uchida T; Imai K; Wada H; Kinoshita T; Murate T; Mizutani S
    Leukemia; 1995 Nov; 9(11):1926-34. PubMed ID: 7475285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.
    Miyazaki K; Yamasaki N; Oda H; Kuwata T; Kanno Y; Miyazaki M; Komeno Y; Kitaura J; Honda Z; Warming S; Jenkins NA; Copeland NG; Kitamura T; Nakamura T; Honda H
    Blood; 2009 May; 113(19):4702-10. PubMed ID: 19234145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EVI1 activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22).
    De Weer A; Poppe B; Cauwelier B; Carlier A; Dierick J; Verhasselt B; Philippé J; Van Roy N; Speleman F
    BMC Cancer; 2008 Jul; 8():193. PubMed ID: 18613965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics.
    Reid AG; De Melo VA; Elderfield K; Clark I; Marin D; Apperley J; Naresh KN
    Leuk Res; 2009 Mar; 33(3):418-25. PubMed ID: 18760473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal regulation of the myc gene in myeloid leukemia.
    Gopal V; Kadam P; Preisler H; Hulette B; Li YQ; Steele P; Freeman J; Banavali S
    Med Oncol Tumor Pharmacother; 1992; 9(3):139-47. PubMed ID: 1341325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.